Daewoong Pharmaceutical has released the results of a study on the indication of its P-CAB (potassium-competitive acid blockers)-based drug, Fexuclue (fexuprazan hydrochloride), to treat gastritis at the United European Gastroenterology Week (UEGW) 2022.Daewoong said it unveiled the phase 3 clinical
The Asan Medical Center (AMC), where a nurse’s death occurred in July, should withdraw its Grade 1 rating in the evaluation of the adequacy in treating acute stroke, a lawmaker said.According to the evaluation of adequacy in handling acute stroke made public by the Health Insurance Review and Assess
A multinational research team including Professor Bae Hee-joon of Seoul National University Bundang Hospital (SNUBH) found that ancestry specific stroke genetic risk factors strongly predicted ischemic stroke in European, East Asian and African ancestry.Genome-wide association studies (GWASs) identi
Yongin Severance Hospital said it succeeded in treating a 77-day-old baby suffering from spinal muscular atrophy (SMA) by administering Novartis’ Zolgensma, an ultra-expensive gene therapy covered by the national health insurance program.According to the hospital, it is the nation’s first case of us
The government said 780,000 doses of Pfizer's BA.1-based bivalent vaccine, an improved vaccine developed to respond to the Omicron variant, will arrive in Korea on Thursday.This is the first shipment of Pfizer's bivalent batch to arrive in Korea and comes after the Ministry of Food and Drug Safety g
The Fair Trade Commission (FTC) said AstraZeneca and Alvogen would face a $1.85 million fine together for reaching an unfair deal to prevent the launch of a generic version of AstraZeneca’s Zoladex (ingredient: Gosereline), a drug for breast and prostate cancer, in Korea.The FTC imposed a correction
Foreign residents in Korea paid nearly 1.58 trillion won ($1.11 billion) in health insurance premiums, and the number of foreigners caught illegally receiving insurance money decreased significantly last year.Based on the analysis of data at the National Health Insurance Service, Rep. Koh Young-in o
Lunit, a company specializing in medical artificial intelligence (AI) solutions, said on Thursday that the number of domestic and foreign medical institutions using its AI imaging solutions for mammography and chest X-ray has surpassed 1,000.Lunit Insight CXR diagnoses 10 chest diseases such as lung
CHA Bundang Medical Center identified the gastroesophageal variceal bleeding risk factor when using a combination therapy of Tecentriq (ingredient: atezolizumab) and Avastin (bevacizumab) for treating hepatocellular carcinoma (HCC). HCC is the sixth most common cancer worldwide, but the development
Dong-A ST said Wednesday it released the results of the phase 3 clinical trial of Evogliptin plus three-drug combination therapy at the European Association for the Study of Diabetes (EASD) conference in Stockholm from Sept. 19-23.Professor Yoon Keon-ho of the Department of Endocrine Metabolism at S
Gangnam Severance Hospital announced a blue print to become the first "urban-type smart hospital" in Seoul, with the goal of completing construction by 2030. The project is part of the hospital’s celebration of 40th anniversary next year.At a news conference on Wednesday, Gangnam Severance Hospital
Enhertu (trastuzumab deruxtecan) and Trodelvy (sacituzumab govitecan), the two breast cancer therapies based on the next-generation antibody-drug conjugates (ADC), will likely take the lead in the cancer’s innovative treatment across the board.The first-generation ADC developed by Roche, Kadcyla (tr
ViGenCell, an immune cell therapy developer, said the Ministry of Food and Drug Safety has granted compassionate use approval for VT-Tri, an acute myeloid leukemia (AML) treatment.Compassionate use permits the use of investigational drugs for treating patients with severe and life-threatening illnes
The Korea Exchange (KRX) held a corporate review committee on Thursday and decided to maintain the listing of SillaJen on the tech-heavy Kosdaq market.With the decision, SillaJen's shares will resume trading on Thursday.The company used to be one of the most prominent local biopharmaceutical compani
As the spread of Covid-19 has subsided, the government has removed the mandatory Covid-19 testing requirement for patients visiting emergency rooms (ER).Until now, the government has required people to undergo a Covid-19 polymerase chain reaction (PCR) test or a rapid antigen test before visiting th
Vaccine hesitancy is a global issue but particularly immunization among pregnant women is a controversial issue because of myths regarding vaccination safety for the mother and baby.As new bivalent Covid-19 vaccines are rolling out again nationwide, mothers should be equipped with the latest knowled
“Patents become more important for corporate sell-off or licensing. No matter how good your technology is, if you have a patent that can be invalidated, they annul your patents and use them for free instead of spending money to license them. Numerous companies in the market, such as Teva, invalidate
Spinraza (nusinersen), the first spinal muscular atrophy (SMA) treatment that won the insurance coverage quickly since its introduction in Korea, is experiencing difficulty expanding its reimbursement standards.At stake is the “suspension of reimbursement” for SMA 3-type patients.There were four exp
Boryung said on Wednesday that its new anticancer drug candidate, BR101801, for treating peripheral T cell lymphoma (PTCL) has been designated as an orphan drug by the U.S. Food and Drug Administration (FDA).Peripheral T cell lymphoma is a malignant tumor originating from T cells, which are immune c
The excessive desire among Korean female teenagers and young adults to stay skinny and thin is raising health concerns, as many of them are turning toward bulimia nervosa, an eating disorder, as a solution to achieve their desired body weight.Bulimia nervosa is a serious eating disorder where patien